Terapiområde
Läkemedel
Upptäck mer
Patienter och anhöriga
PHARMA SVERIGE
Terapiområde
Hjärta, njure, diabetes
Oftalmologi
Onkologi
Kvinnohälsa
Hemofili
Läkemedel
Hjärta, njure, diabetes
Beyonttra
Kerendia
Verquvo
Xarelto
Oftalmologi
Eylea
Onkologi
Nubeqa
Xofigo
Vitrakvi
Kvinnohälsa
Mirena
Kyleena
Jaydess
Nova T 380
Qlaira
Hemofili
Jivi
Upptäck mer
Mediabibliotek
Kommande utbildningar
Resurser
Önskar du få information från Bayer?
Bayer Play
Lunch Talks
Patienter och anhöriga
more_vert
Om Xofigo®
Studier
Dosering
Video series on advanced prostate cancer management
Mediabibliotek
Om Xofigo®
Studier
Dosering
Video series on advanced prostate cancer management
Mediabibliotek
Xofigo mediabibliotek
Welcome video for the series Episode 1-5
Join Dr. Daniel Heinrich, a clinical oncologist from Norway, and Dr. Joe O'Sullivan from Belfast, Northern Ireland, a...
Episode No. 1 - Introduction to Radium-223 in clinical pr...
Learn about the development and unique properties of Radium-223.
Episode No. 5 - Introduction to post-radium-223 treatment...
Discuss next steps for patients after completing Radium-223 therapy.
Episode No. 2 - Introduction to clinical evidence for Rad...
Explore findings from the pivotal ALSYMPCA trial and its impact on treatment.
Episode No. 3 - Introduction to patient selection for Rad...
Understand criteria for selecting ideal candidates and the role of patient education.
Episode No. 4 - Introduction to monitoring and management...
Discover essential monitoring practices for effective patient management.
Xofigos verkningsmekanism
11-05-23 Bayer AS Xofigo är ett terapeutiskt alfastrålande läkemedel.
Xofigo Manufacturing in Oslo
01-07-24 Bayer AS Bayer har etablerat en unik och dedikerad produktionsanläggning för XOFIGO i Oslo - en säker och...